Pharmacotherapy of intraocular pressure part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides

Ciro Costagliola; Roberto Dell'Omo; Mario R. Romano; Michele Rinaldi; Lucia Zeppa; Francesco Parmeggiani

doi:10.1517/14656560903300129

Pharmacotherapy of intraocular pressure part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides

Ciro Costagliola, Roberto Dell'Omo, Mario R. Romano, Michele Rinaldi, Lucia Zeppa, Francesco Parmeggiani

Istituto Clinico Humanitas

Research output: Contribution to journal › Article › peer-review

Abstract

The second part of this two part review (please see Expert Opinion on Pharmacotherapy 10(16)) reports the characteristics of other antiglaucoma medications: systemic (acetazomide) and topical (dorzolamide and brinzolamide) carbonic anhydrase inhibitors, which suppress aqueous humour formation; and prostaglandin analogues (latanoprost and travoprost) and prostamides (bimatoprost), which raise aqueous humour outflow. The pharmacologic properties of each compound and its efficacy in the medical treatment of glaucoma, mainly the primary open-angle form, are discussed briefly, focusing on the clinical evidence supporting their use.

Original language	English
Pages (from-to)	2859-2870
Number of pages	12
Journal	Expert Opinion on Pharmacotherapy
Volume	10
Issue number	17
DOIs	https://doi.org/10.1517/14656560903300129
Publication status	Published - Dec 2009

Keywords

Acetazolamide
Bimatoprost
Brinzolamide
Carbonic anhydrase inhibitors
Dorzolamide
Glaucoma
Latanoprost
Prostaglandin analogues
Prostamides
Travoprost

ASJC Scopus subject areas

Pharmacology (medical)
Pharmacology

Access to Document

10.1517/14656560903300129

Fingerprint Dive into the research topics of 'Pharmacotherapy of intraocular pressure part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides'. Together they form a unique fingerprint.

Cite this

Pharmacotherapy of intraocular pressure part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides. / Costagliola, Ciro; Dell'Omo, Roberto; Romano, Mario R.; Rinaldi, Michele; Zeppa, Lucia; Parmeggiani, Francesco.

In: Expert Opinion on Pharmacotherapy, Vol. 10, No. 17, 12.2009, p. 2859-2870.

Research output: Contribution to journal › Article › peer-review

@article{74d21fc800cd4eb5a36ad4c431f81e7f,

title = "Pharmacotherapy of intraocular pressure part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides",

abstract = "The second part of this two part review (please see Expert Opinion on Pharmacotherapy 10(16)) reports the characteristics of other antiglaucoma medications: systemic (acetazomide) and topical (dorzolamide and brinzolamide) carbonic anhydrase inhibitors, which suppress aqueous humour formation; and prostaglandin analogues (latanoprost and travoprost) and prostamides (bimatoprost), which raise aqueous humour outflow. The pharmacologic properties of each compound and its efficacy in the medical treatment of glaucoma, mainly the primary open-angle form, are discussed briefly, focusing on the clinical evidence supporting their use.",

keywords = "Acetazolamide, Bimatoprost, Brinzolamide, Carbonic anhydrase inhibitors, Dorzolamide, Glaucoma, Latanoprost, Prostaglandin analogues, Prostamides, Travoprost",

author = "Ciro Costagliola and Roberto Dell'Omo and Romano, {Mario R.} and Michele Rinaldi and Lucia Zeppa and Francesco Parmeggiani",

year = "2009",

month = dec,

doi = "10.1517/14656560903300129",

language = "English",

volume = "10",

pages = "2859--2870",

journal = "Expert Opinion on Pharmacotherapy",

issn = "1465-6566",

publisher = "Taylor and Francis Ltd.",

number = "17",

}

TY - JOUR

T1 - Pharmacotherapy of intraocular pressure part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides

AU - Costagliola, Ciro

AU - Dell'Omo, Roberto

AU - Romano, Mario R.

AU - Rinaldi, Michele

AU - Zeppa, Lucia

AU - Parmeggiani, Francesco

PY - 2009/12

Y1 - 2009/12

N2 - The second part of this two part review (please see Expert Opinion on Pharmacotherapy 10(16)) reports the characteristics of other antiglaucoma medications: systemic (acetazomide) and topical (dorzolamide and brinzolamide) carbonic anhydrase inhibitors, which suppress aqueous humour formation; and prostaglandin analogues (latanoprost and travoprost) and prostamides (bimatoprost), which raise aqueous humour outflow. The pharmacologic properties of each compound and its efficacy in the medical treatment of glaucoma, mainly the primary open-angle form, are discussed briefly, focusing on the clinical evidence supporting their use.

AB - The second part of this two part review (please see Expert Opinion on Pharmacotherapy 10(16)) reports the characteristics of other antiglaucoma medications: systemic (acetazomide) and topical (dorzolamide and brinzolamide) carbonic anhydrase inhibitors, which suppress aqueous humour formation; and prostaglandin analogues (latanoprost and travoprost) and prostamides (bimatoprost), which raise aqueous humour outflow. The pharmacologic properties of each compound and its efficacy in the medical treatment of glaucoma, mainly the primary open-angle form, are discussed briefly, focusing on the clinical evidence supporting their use.

KW - Acetazolamide

KW - Bimatoprost

KW - Brinzolamide

KW - Carbonic anhydrase inhibitors

KW - Dorzolamide

KW - Glaucoma

KW - Latanoprost

KW - Prostaglandin analogues

KW - Prostamides

KW - Travoprost

UR - http://www.scopus.com/inward/record.url?scp=73149117367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73149117367&partnerID=8YFLogxK

U2 - 10.1517/14656560903300129

DO - 10.1517/14656560903300129

M3 - Article

C2 - 19929706

AN - SCOPUS:73149117367

VL - 10

SP - 2859

EP - 2870

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 17

ER -